← Back to Search

Spinal anesthesia for Urinary Retention

N/A
Waitlist Available
Led By Laura Martin, DO
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within the first week after surgery
Awards & highlights

Study Summary

The purpose of the study is to compare the risk of being unable to urinate shortly after surgery, also called acute post-operative urinary retention (POUR) between spinal and general anesthesia in women who undergo outpatient pelvic organ prolapse with stress urinary incontinence surgery.

Eligible Conditions
  • Urinary Retention
  • Uterine Prolapse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within the first week after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within the first week after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of postoperative urinary retention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Spinal anesthesiaExperimental Treatment1 Intervention
Subjects randomized to spinal anesthesia will receive Bupivacaine 0.75%, 8-12.5 mg dose depending on estimated duration of surgery and anesthesiologist decision. In addition to spinal anesthesia, these subjects will possibly have concurrent administration of fentanyl, midazolam, and propofol so that they are mildy sedated or sleeping.
Group II: General anesthesiaActive Control1 Intervention
Subjects randomized to general anesthesia will receive propofol induction, in combination with a muscle relaxant and inhalational gas per anesthesia standard of care at our institution
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal anesthesia
2017
Completed Phase 4
~3960

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,026 Previous Clinical Trials
1,366,008 Total Patients Enrolled
4 Trials studying Urinary Retention
913 Patients Enrolled for Urinary Retention
Laura Martin, DOPrincipal InvestigatorClevland Clinic Florida
2 Previous Clinical Trials
390 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025